首页 > 市场调查报告书 > 製药

自体免疫疾病

市场调查报告书

商品编码

1566143

自体免疫疾病诊断市场规模、份额、成长分析、按产品、按测试类型、按疾病类型、按最终用户、按地区 - 行业预测，2024-2031 年

Autoimmune Disease Diagnostics Market Size, Share, Growth Analysis, By Product, By Test Type, By Disease Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月06日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，自体免疫疾病诊断的全球市场规模为43.8亿美元，从2023年的45.6亿美元成长到2031年的63.2亿美元，预计在预测期内（2024-2031年）将以复合年增长率成长。

自体免疫疾病诊断市场是由自体免疫疾病的全球流行所推动的，已知这些疾病会影响各种器官和系统，需要及时、准确的诊断以进行有效的管理，并且由于自体免疫疾病的增加，该市场正在显着扩张。发病率的增加是由遗传倾向、环境影响和生活方式改变等因素驱动的，从而推动了对客製化诊断测试来识别和监测这些疾病的需求。同时，医疗技术的进步大大提高了诊断技术的准确性和效率，引入了各种实验室测试、影像技术和专门化验，有助于识别特定的自体免疫疾病。这些创新使医疗保健专业人员能够就患者护理做出更明智的决策。此外，患者和医疗保健提供者对自体免疫疾病的认识不断提高，增加了早期检测的力度，这对于改善患者的治疗结果和预防併发症至关重要。因此，全球自体免疫疾病诊断市场预计将出现强劲成长，其中美国市场等预计将在预测期内保持强劲的复合年增长率。这一趋势强调了自体免疫疾病在医疗保健中的早期检测和有效管理的重要性，并为诊断工具的进一步创新和开发提供了重要机会。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Abbott Laboratories
Thermo Fisher Scientific Inc.
Siemens AG
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc.
Quest Diagnostics Incorporated
Hologic, Inc.
Danaher Corporation
Inova Diagnostics, Inc.
PerkinElmer Germany Diagnostics GmbH
Grifols, SA
Bio-Techne Corporation
Menarini Group
Myriad Genetics, Inc.
Medac GmbH
ImmunArray
Exagen Inc.
ORGENTEC Diagnostika GmbH
Seramun Diagnostica GmbH
SQI Diagnostics Inc.

简介目录

Product Code: SQMIG35D2178

Global Autoimmune Disease Diagnostics Market size was valued at USD 4.38 billion in 2022 and is poised to grow from USD 4.56 billion in 2023 to USD 6.32 billion by 2031, growing at a CAGR of 4.15% during the forecast period (2024-2031).

The autoimmune disease diagnostics market is witnessing significant expansion driven by the escalating prevalence of autoimmune conditions globally, which are known to impact various organs and systems, necessitating timely and precise diagnosis for effective management. This increase in incidence is fueled by factors such as genetic predisposition, environmental influences, and shifting lifestyle patterns, boosting the demand for diagnostic tests tailored to identify and monitor these diseases. Concurrently, advancements in medical technology have greatly enhanced the accuracy and efficiency of diagnostic methodologies, with a diverse range of laboratory tests, imaging techniques, and specialized assays emerging to facilitate the identification of specific autoimmune disorders. These innovations empower healthcare professionals to make more informed decisions regarding patient care. Additionally, rising awareness among both patients and healthcare providers about autoimmune diseases has intensified the push for early detection, which is critical for improving patient outcomes and preventing complications. As a result, the global autoimmune disease diagnostics market is anticipated to experience robust growth, with the US market expected to sustain a strong compound annual growth rate (CAGR) in the coming forecast period. This trend signifies vast opportunities for further innovation and development of diagnostic tools, reinforcing the importance of early detection and effective management of autoimmune diseases in healthcare initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Autoimmune Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Autoimmune Disease Diagnostics Market Segmental Analysis

Global Autoimmune Disease Diagnostics Market is segmented by Product, Test Type, Disease Type, End User, and Region. Based on Product, the market is segmented into Reagents and consumables, Instruments. Based on Test Type, the market is segmented into Antinuclear antibody tests, Urinalysis, C-reactive protein (CRP), Complete blood count (CBC), Autoantibody tests, Other tests. Based on Disease Type, the market is segmented into Systemic autoimmune disease (Rheumatoid arthritis, Systemic lupus erythematosus (SLE), Psoriasis, Multiple sclerosis, Other systemic autoimmune diseases), Localized autoimmune disease (Inflammatory bowel disease, Type 1 diabetes, Thyroid, Other localized autoimmune diseases). Based on End User, the market is segmented into Hospitals, Diagnostics centers, Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Autoimmune Disease Diagnostics Market

Increased awareness among patients and healthcare professionals regarding autoimmune diseases has emerged as a significant market driver for the Global Autoimmune Disease Diagnostics market. As individuals become more knowledgeable about the symptoms and complexities of these diseases, there is a marked shift towards early recognition and timely diagnosis. This proactive approach facilitates the prompt initiation of treatment and effective management strategies, ultimately enhancing patient outcomes. Consequently, the heightened awareness fuels a growing demand for advanced diagnostic tests that support early detection and ongoing monitoring of autoimmune conditions, thereby driving innovations and investments within the diagnostics sector.

Restraints in the Global Autoimmune Disease Diagnostics Market

The high cost of autoimmune disease diagnostic tests serves as a significant market restraint for the global Autoimmune Disease Diagnostics market. Advanced and specialized testing often comes with substantial expenses that can restrict access for patients, particularly in underdeveloped or underinsured regions where healthcare resources are limited. This financial barrier not only deters patients from seeking timely diagnosis but also impedes the widespread adoption of innovative diagnostic solutions. Furthermore, inadequate insurance coverage compounds this issue, leading to delays in diagnosis and treatment, ultimately reducing the overall demand for such diagnostic tools and limiting their market growth potential.

Market Trends of the Global Autoimmune Disease Diagnostics Market

The Global Autoimmune Disease Diagnostics market is experiencing significant growth, driven by rapid technological advancements in medical diagnostics. Innovations such as high-throughput screening, next-generation sequencing, and advanced imaging techniques are enhancing the accuracy and efficiency of autoimmune disease detection and monitoring. These state-of-the-art diagnostic tools enable healthcare providers to identify specific autoimmune disorders more reliably and swiftly, thereby improving patient outcomes. The rising prevalence of autoimmune diseases and increasing healthcare expenditure further fuel market demand, prompting investment in research and development of specialized assays and laboratory tests tailored for autoimmune conditions. Overall, the market is poised for robust expansion.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Value Chain Analysis
PESTEL Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Autoimmune Disease Diagnostics Market by Product

Market Overview
Instruments
Reagents and consumables

Autoimmune Disease Diagnostics Market by Test Type

Market Overview
Antinuclear antibody tests
Urinalysis
C-reactive protein (CRP)
Complete blood count (CBC)
Autoantibody tests
Other tests

Autoimmune Disease Diagnostics Market by Disease Type

Market Overview
Systemic autoimmune disease
- Rheumatoid arthritis
- Systemic lupus erythematosus (SLE)
- Psoriasis
- Multiple sclerosis
- Other systemic autoimmune diseases
Localized autoimmune disease
- Inflammatory bowel disease
- Type 1 diabetes
- Thyroid
- Other localized autoimmune diseases

Autoimmune Disease Diagnostics Market by End User

Market Overview
Hospitals
Diagnostics centers
Other end-users

Autoimmune Disease Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inova Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Germany Diagnostics GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menarini Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medac GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ImmunArray
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exagen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ORGENTEC Diagnostika GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seramun Diagnostica GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SQI Diagnostics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments